Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study.
暂无分享,去创建一个
H. Kantarjian | J. Cortes | K. Yee | A. Advani | D. Rizzieri | E. Feldman | M. Toal | D. Rizzieri | A. Charman | Richard Spruyt | Jorge E. Cortés | Eric Feldman | Karen Yee | Martin Toal